Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Smart Eye in conjunction with a directed new issue of shares
Mandate

Vinge advises Smart Eye in conjunction with a directed new issue of shares

October 06, 2020 Capital Markets and Public M&A

Vinge has advised Smart Eye AB in connection with a directed new issue of 1 511 898 new shares at a subscription price of SEK 125 per share, which means that Smart Eye will acquire MSEK 189 prior to issue costs.

The subscription price has been determined through an accelerated book building procedure and corresponds to a discount of 2.9 per cent compared with the volume‑weighted average price on Nasdaq First North Growth Market on 5 October 2020.

Vinge’s team consisted of Anders Strid, Edin Agic and Jacob Benzow.

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

 Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

 Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

 Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026